Figure 2.
SMAD phosphorylation and hepcidin expression. (A) Pacritinib decreases STAT5 and SMAD1/5/9 phosphorylation and (B) HAMP (hepcidin) messenger RNA (mRNA) levels in human HepG2 cells stimulated by BMP6 for 24 hours.

SMAD phosphorylation and hepcidin expression. (A) Pacritinib decreases STAT5 and SMAD1/5/9 phosphorylation and (B) HAMP (hepcidin) messenger RNA (mRNA) levels in human HepG2 cells stimulated by BMP6 for 24 hours.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal